BNP Paribas Financial Markets’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,108
| Closed | -$1.07K | – | 3374 |
|
|
2022
Q4 | $1.07K | Buy |
6,108
+4,294
| +237% | +$752 | ﹤0.01% | 3131 |
|
|
2022
Q3 | $787 | Sell |
1,814
-3,082
| -63% | -$1.34K | ﹤0.01% | 3751 |
|
|
2022
Q2 | $4.17K | Sell |
4,896
-50,889
| -91% | -$43.3K | ﹤0.01% | 3198 |
|
|
2022
Q1 | $307K | Buy |
55,785
+38,998
| +232% | +$215K | ﹤0.01% | 2421 |
|
|
2021
Q4 | $162K | Buy |
16,787
+8,289
| +98% | +$80.2K | ﹤0.01% | 2813 |
|
|
2021
Q3 | $152K | Buy |
8,498
+6,678
| +367% | +$119K | ﹤0.01% | 2555 |
|
|
2021
Q2 | $44.4K | Sell |
1,820
-11,421
| -86% | -$279K | ﹤0.01% | 2705 |
|
|
2021
Q1 | $351K | Buy |
13,241
+4,609
| +53% | +$122K | ﹤0.01% | 2230 |
|
|
2020
Q4 | $65.5K | Sell |
8,632
-1,014
| -11% | -$7.7K | ﹤0.01% | 2778 |
|
|
2020
Q3 | $48.3K | Buy |
9,646
+7,047
| +271% | +$35.3K | ﹤0.01% | 2862 |
|
|
2020
Q2 | $15.5K | Sell |
2,599
-8,924
| -77% | -$53.4K | ﹤0.01% | 2876 |
|
|
2020
Q1 | $51.3K | Buy |
11,523
+6,727
| +140% | +$29.9K | ﹤0.01% | 2918 |
|
|
2019
Q4 | $45.6K | Sell |
4,796
-1,434
| -23% | -$13.6K | ﹤0.01% | 3038 |
|
|
2019
Q3 | $48.9K | Buy |
6,230
+1,666
| +37% | +$13.1K | ﹤0.01% | 2852 |
|
|
2019
Q2 | $71.8K | Sell |
4,564
-2,921
| -39% | -$45.9K | ﹤0.01% | 2611 |
|
|
2019
Q1 | $135K | Buy |
7,485
+7,446
| +19,092% | +$135K | ﹤0.01% | 2366 |
|
|
2018
Q4 | $627 | Sell |
39
-13
| -25% | -$209 | ﹤0.01% | 3302 |
|
|
2018
Q3 | $1.25K | Buy |
+52
| New | +$1.25K | ﹤0.01% | 3633 |
|